Orderlymeds

Orderlymeds is an online-only telehealth pharmacy that focuses on GLP-1 receptor agonist weight-loss injections—primarily compounded semaglutide and tirzepatide—sold in 4-, 8-, and 12-week subscription kits. Prices sit in the mid-range bracket: about $299-$549 per month, including medication, tele-consult, supplies, and free 2-day shipping; no insurance is required. The site also stocks supporting items such as alcohol swabs, sharps containers, and vitamin B12 lipo-combo add-ons, all bundled into the same checkout flow. The brand’s core promise is “doctor-guided, pharmacy-delivered” in one seamless loop: patients complete an intake form, are reviewed by a U.S.-licensed clinician within 24 h, and receive medication from an affiliated PCAB-certified compounding pharmacy. All vials are compounded on-demand in the United States, labeled with batch and beyond-use dates, and shipped cold-chain in reusable gel-pack mailers. Orderlymeds markets transparency—posting third-party lab results for potency and sterility on each product page—and offers a 30-day refund if treatment is discontinued for medical reasons. Typical buyers are 25-55-year-old professionals who want clinically proven weight-loss medication without brick-and-mortar clinic visits or insurance hurdles; many report BMI just above insurance-cutoff thresholds or prefer privacy. The brand speaks to value-driven pragmatists who track macros, use wearables, and favor subscription convenience over luxury aesthetics. Orderlymeds competes with national telehealth platforms, cash-pay pharmacy networks, and med-spa chains that also prescribe GLP-1 drugs. It differentiates by keeping the entire stack—consult, compounding, and fulfillment—under one digital roof, avoiding third-party pharmacy delays and offering flat, published pricing with no membership or hidden consult fees.